TLP Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-14,686
Closed -$1.64M 228
2018
Q3
$1.58M Sell
14,686
-9,806
-40% -$980K 2.49% 7
2018
Q2
$2.09M Buy
24,492
+6,361
+35% +$522K 3.17% 5
2018
Q1
$1.4M Buy
18,131
+6,624
+58% +$533K 0.96% 11
2017
Q4
$972K Buy
11,507
+11,466
+27,966% +$976K 0.67% 10
2017
Q3
$4K Buy
+41
New +$3.36K ﹤0.01% 461

Other funds holding LLY

TLP Group's LLY Position: Q4 2018 in Review

TLP Group sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 14,686 shares — an estimated $1.64M sold.

TLP Group first reported a position in LLY in Q3 2017 and held it in 5 quarters. The position peaked at $2.09M in Q2 2018. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • TLP Group reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 14,686 Eli Lilly shares in Q4 2018, an estimated $1.64M.
  • TLP Group first reported a position in Eli Lilly in Q3 2017 and held it in 5 quarters.
  • TLP Group's Eli Lilly position peaked at $2.09M in Q2 2018.
  • 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.